Cargando…
The PAV trial: Does lactobacillus prevent post-antibiotic vulvovaginal candidiasis? Protocol of a randomised controlled trial [ISRCTN24141277]
BACKGROUND: Complementary and alternative medicines are used by many consumers, and increasingly are being incorporated into the general practitioner's armamentarium. Despite widespread usage, the evidence base for most complementary therapies is weak or non-existent. Post-antibiotic vulvovagin...
Autores principales: | Pirotta, Marie, Gunn, Jane, Chondros, Patty, Grover, Sonia, Hurley, Susan, Garland, Suzanne |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC521199/ https://www.ncbi.nlm.nih.gov/pubmed/15046642 http://dx.doi.org/10.1186/1471-2296-5-5 |
Ejemplares similares
-
Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
por: Ge, Gai, et al.
Publicado: (2022) -
Recurrent Vulvovaginal Candidiasis: a Dynamic Interkingdom Biofilm Disease of Candida and Lactobacillus
por: McKloud, Emily, et al.
Publicado: (2021) -
Candidiasis vulvovaginal: revisión bibliográfica.
por: Caballero Salmeron, María Esther
Publicado: (1995) -
New Treatments for Vulvovaginal Candidiasis
por: Faro, Sebastian
Publicado: (1996) -
Changing Trends of Vulvovaginal Candidiasis
por: Vijaya, Doddaiah, et al.
Publicado: (2014)